Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia

Experimental and Therapeutic Medicine

Volumn 7, Issue 1, 2013, Pages 149-154

  Xu, Ruilong ^a,b   Zheng, Zhaojing ^b   Ma, Yongjun ^b   Hu, Yingping ^b   Zhuang, Shunhong ^b   Wei, Bin ^b   Lu, Jianxing ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b ZHEJIANG NORMAL UNIVERSITY   (China)

Author keywords

Adult; Chronic immune thrombocytopenia; Cytokine profile; Natural killer T cells; Regulatory T cells

Indexed keywords

CD3 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLOOD SAMPLING; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; TH1 TH2 BALANCE; THROMBOCYTE COUNT;

EID: 84887952212     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1386     Document Type: Article

References (27)

1. Rodeghiero F, Stasi R, Gernsheimer T, etal: Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113: 2386-2393, 2009.
2. Gernsheimer T: Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis. Oncologist 14: 12-21, 2009.
3. Zhou B, Zhao H, Yang RC and Han ZC: Multi-dysfunctional pathophysiology in ITP. Crit Rev Oncol Hematol 54: 107-116, 2005.
4. Semple JW: Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev 16: 9-12, 2002.
5. Coopamah MD, Garvey MB, Freedman J and Semple JW: Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update. Transfus Med Rev 17: 69-80, 2003.
6. Panitsas FP, Theodoropoulou M, Kouraklis A, etal: Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 103: 2645-2647, 2004.
7. Wang T, Zhao H, Ren H, etal: Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica 90: 914-923, 2005.
8. Zhang J, Ma D, Zhu X, Qu X, Ji C and Hou M: Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica 94: 1326-1329, 2009.
9. von Boehmer H: Mechanisms of suppression by suppressor Tcells. Nat Immunol 6: 338-344, 2005.
10. + regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol 78: 139-143, 2007.
11. + T cells in patients with idiopathic thrombocytopenic purpura. Thromb Res 120: 187-193, 2007.
12. Yu J, Heck S, Patel V, etal: Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood 112: 1325-1328, 2008.
13. Kronenberg M and Gapin L: The unconventional lifestyle of NKT cells. Nat Rev Immunol 2: 557-568, 2002.
14. Wilson SB and Delovitch TL: Janus-like role of regulatory iNKT cells in autoimmune disease and tumor immunity. Nat Rev Immunol 3: 211-222, 2003.
15. Johansson U, Macey MG, Kenny D, Provan D and NewlandAC: Alpha-galactosylceramide-driven expansion of human natural killer T cells is inhibited by prednisolone treatment. Br JHaematol125: 400-404, 2004.
16. + Tregs and NKT cells: regulators regulating regulators. Trends Immunol 27: 322-327, 2006.
17. Zhang L, Li H, Zhao H, Ji L and Yang R: Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese center. Eur J Haematol 70: 196-197, 2003.
18. Ziegler SF: FOXP3: of mice and men. Annu Rev Immunol 24: 209-226, 2006.
19. + T reg cells. J Exp Med 203: 1701-1711, 2006.
20. Johansson U, Macey MG, Kenny D, Provan AB and NewlandAC: The role of natural killer T (NKT) cells in immune thrombocytopenia: is strong in vitro NKT cell activity related to the development of remission? Br J Haematol 129: 564-565, 2005.
21. Ho LP, Urban BC, Jones L, Ogg GS and McMichael AJ: CD4-CD8αα subset of CD1d-restricted NKT cells controls Tcell expansion. J Immunol 172: 7350-7358, 2004.
22. Cao J, Chen C, Li L, etal: Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia. J Clin Immunol32: 523-529, 2012.
23. Wolk K, Witte E, Witte K, Warszawska K and Sabat R: Biology of interleukin-22. Semin Immunopathol 32: 17-31, 2010.
24. + regulatory T cells suppress NKT cell functions. Cancer Res 63: 4516-4520, 2003.
25. + regulatory T cells? Eur JImmunol35: 1193-1200, 2005.
26. Provan D, Stasi R, Newland AC, etal: International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115: 168-186, 2010.
27. Zehnder JL, Semple JW, Imbach P, Neufeld EJ, Buchanan GR and Cines DB: Future research in ITP: an ICIS consensus. Ann Hematol 89 (Suppl1): S19-S23, 2010.